Advances in Prognostic Methylation Biomarkers for Prostate Cancer

There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dilys Lam, Susan Clark, Clare Stirzaker, Ruth Pidsley
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-10-01
Series:Cancers
Assuntos:
DNA methylation
epigenetics
biomarkers
circulating DNA
cfDNA
prostate cancer
Acceso en liña:https://www.mdpi.com/2072-6694/12/10/2993
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares